| scholarly article | Q13442814 |
| P356 | DOI | 10.4161/AUTO.6083 |
| P8608 | Fatcat ID | release_pthtccpepbaxliqfo2awfybw7i |
| P698 | PubMed publication ID | 18424910 |
| P5875 | ResearchGate publication ID | 5427700 |
| P2093 | author name string | Gabriel Lopez-Berestein | |
| Seiji Kondo | |||
| Bulent Ozpolat | |||
| Ugur Akar | |||
| Banu Arun | |||
| Yasuko Kondo | |||
| Angela Sanguino | |||
| Magaly Barria | |||
| Ana Tari | |||
| Arturo Chaves-Reyez | |||
| P433 | issue | 5 | |
| P921 | main subject | breast cancer | Q128581 |
| autophagy | Q288322 | ||
| cell death | Q2383867 | ||
| P304 | page(s) | 669-679 | |
| P577 | publication date | 2008-04-10 | |
| P1433 | published in | Autophagy | Q1255295 |
| P1476 | title | Silencing of Bcl-2 expression by small interfering RNA induces autophagic cell death in MCF-7 breast cancer cells | |
| P478 | volume | 4 |
| Q42798512 | 5-Azacytidine specifically inhibits the NIH-3T3 PCD process induced by TNF-alpha and cycloheximide via affecting BCL-XL. |
| Q39071997 | Acetazolamide triggers death inducing autophagy in T-47D breast cancer cells. |
| Q58801878 | Activating Autophagy Enhanced the Antitumor Effect of Antibody Drug Conjugates Rituximab-Monomethyl Auristatin E |
| Q37145468 | Activation of Autophagy Pathway Suppresses the Expression of iNOS, IL6 and Cell Death of LPS-Stimulated Microglia Cells |
| Q39210293 | Alternative Pathways of Cancer Cell Death by Rottlerin: Apoptosis versus Autophagy. |
| Q35798939 | Andrographolide Analogue Induces Apoptosis and Autophagy Mediated Cell Death in U937 Cells by Inhibition of PI3K/Akt/mTOR Pathway |
| Q30579272 | Antagonism of tumoral prolactin receptor promotes autophagy-related cell death |
| Q44441021 | Anti-cell death engineering of CHO cells: co-overexpression of Bcl-2 for apoptosis inhibition, Beclin-1 for autophagy induction |
| Q38388106 | Antiapoptotic Bcl-2 protein as a potential target for cancer therapy: A mini review |
| Q39421552 | Antitumor effects of cytoplasmic delivery of an innate adjuvant receptor ligand, poly(I:C), on human breast cancer |
| Q41167283 | Apatinib promotes autophagy and apoptosis through VEGFR2/STAT3/BCL-2 signaling in osteosarcoma |
| Q38660093 | Apogossypolone induces apoptosis and autophagy in nasopharyngeal carcinoma cells in an in vitro and in vivo study |
| Q39328827 | Apogossypolone induces autophagy and apoptosis in breast cancer MCF-7 cells in vitro and in vivo |
| Q38819542 | Attenuated Total Reflectance Fourier Transform Infrared Spectroscopy: An analytical technique to understand therapeutic responses at the molecular level. |
| Q29614564 | Autophagic cell death: the story of a misnomer |
| Q38979982 | Autophagic regulation of cell growth by altered expression of Beclin 1 in triple-negative breast cancer. |
| Q82997243 | Autophagy and cancer therapy |
| Q38104448 | Autophagy and cancer: taking the 'toxic' out of cytotoxics |
| Q27023375 | Autophagy and endocrine resistance in breast cancer |
| Q37662807 | Autophagy and tumorigenesis |
| Q35591562 | Autophagy as a therapeutic target in cancer. |
| Q35639764 | Autophagy induced by deficiency of sphingosine-1-phosphate phosphohydrolase 1 is switched to apoptosis by calpain-mediated autophagy-related gene 5 (Atg5) cleavage |
| Q36767664 | Autophagy inhibition enhances apigenin-induced apoptosis in human breast cancer cells |
| Q36398762 | Autophagy regulation in the development and treatment of breast cancer |
| Q38066407 | Autophagy, apoptosis, mitoptosis and necrosis: interdependence between those pathways and effects on cancer |
| Q35146596 | Autophagy: cancer's friend or foe? |
| Q37930982 | Autophagy: for better or for worse |
| Q46060884 | Bcl-2 complexed with Beclin-1 maintains full anti-apoptotic function. |
| Q36169503 | Bcl-2 confers survival in cisplatin treated cervical cancer cells: circumventing cisplatin dose-dependent toxicity and resistance |
| Q38973420 | Bcl-2 down-regulation by small interfering RNA induces Beclin1-dependent autophagy in human SGC-7901 cells |
| Q38000992 | Bcl-2:Beclin 1 complex: multiple, mechanisms regulating autophagy/apoptosis toggle switch. |
| Q37272761 | Bozepinib, a novel small antitumor agent, induces PKR-mediated apoptosis and synergizes with IFNα triggering apoptosis, autophagy and senescence |
| Q33730108 | C10ORF10/DEPP-mediated ROS accumulation is a critical modulator of FOXO3-induced autophagy |
| Q33888775 | CD24 Expression and differential resistance to chemotherapy in triple-negative breast cancer. |
| Q37178387 | CSC-3436 switched tamoxifen-induced autophagy to apoptosis through the inhibition of AMPK/mTOR pathway |
| Q33674213 | Cellular stress responses: cell survival and cell death |
| Q39531127 | Characterization and comparison of telomere length, telomerase and reverse transcriptase activity and gene expression in human mesenchymal stem cells and cancer cells of various origins |
| Q30513775 | Chloroquine sensitizes breast cancer cells to chemotherapy independent of autophagy |
| Q38689955 | Clinical relevance of autophagic therapy in cancer: Investigating the current trends, challenges, and future prospects |
| Q37338907 | Comprehensive functional analysis of the tousled-like kinase 2 frequently amplified in aggressive luminal breast cancers |
| Q37275481 | Control of autophagy by oncogenes and tumor suppressor genes |
| Q33907663 | Cytotoxic autophagy in cancer therapy |
| Q54454072 | Decreased expression of Beclin 1 in eutopic endometrium of women with adenomyosis. |
| Q36107033 | Delivery of chemo-sensitizing siRNAs to HER2+-breast cancer cells using RNA aptamers |
| Q48101315 | Development of Dual-Pore Coexisting Branched Silica Nanoparticles for Efficient Gene-Chemo Cancer Therapy |
| Q34109699 | Down-regulation of 5-HT1B and 5-HT1D receptors inhibits proliferation, clonogenicity and invasion of human pancreatic cancer cells |
| Q34474347 | Downregulation of autophagy by Bcl-2 promotes MCF7 breast cancer cell growth independent of its inhibition of apoptosis |
| Q39876149 | Effect of Bcl-xL overexpression on apoptosis and autophagy in recombinant Chinese hamster ovary cells under nutrient-deprived condition |
| Q34473662 | Elongation factor-2 kinase regulates TG2/β1 integrin/Src/uPAR pathway and epithelial-mesenchymal transition mediating pancreatic cancer cells invasion |
| Q89522849 | Enabling Combinatorial siRNA Delivery against Apoptosis-Related Proteins with Linoleic Acid and α-Linoleic Acid Substituted Low Molecular Weight Polyethylenimines |
| Q36715054 | Endoplasmic reticulum stress sensitizes human esophageal cancer cell to radiation |
| Q39202309 | Functionalization of the 3'-ends of DNA and RNA strands with N-ethyl-N-coupled nucleosides: a promising approach to avoid 3'-exonuclease-catalyzed hydrolysis of therapeutic oligonucleotides. |
| Q37942090 | Harnessing the cell death pathway for targeted cancer treatment. |
| Q31143548 | Heteroleptic mononuclear compounds of ruthenium(ii): synthesis, structural analyses, in vitro antitumor activity and in vivo toxicity on zebrafish embryos |
| Q37299691 | IBP-mediated suppression of autophagy promotes growth and metastasis of breast cancer cells via activating mTORC2/Akt/FOXO3a signaling pathway |
| Q33925154 | Inhibition of active autophagy induces apoptosis and increases chemosensitivity in cholangiocarcinoma |
| Q39165527 | Inhibition of autophagy enhances cisplatin cytotoxicity in human adenoid cystic carcinoma cells of salivary glands |
| Q39079713 | Inhibition of autophagy induced by TSA sensitizes colon cancer cell to radiation |
| Q39681605 | Inhibition of isoprenylcysteine carboxylmethyltransferase induces autophagic-dependent apoptosis and impairs tumor growth |
| Q37295309 | Interconnections between apoptotic, autophagic and necrotic pathways: implications for cancer therapy development |
| Q36970527 | Is autophagy rather than apoptosis the regression driver in imatinib-treated gastrointestinal stromal tumors? |
| Q39602090 | JS-K, a nitric oxide-releasing prodrug, induces breast cancer cell death while sparing normal mammary epithelial cells |
| Q28297133 | Knockdown of PSMB7 induces autophagy in cardiomyocyte cultures: possible role in endoplasmic reticulum stress |
| Q41860362 | Low-Dose Endothelial-Monocyte-Activating Polypeptide-II Induced Autophagy by Down-Regulating miR-20a in U-87 and U-251 Glioma Cells |
| Q48857817 | MIR506 induces autophagy-related cell death in pancreatic cancer cells by targeting the STAT3 pathway |
| Q38833604 | Mechanisms of autophagy and apoptosis: Recent developments in breast cancer cells |
| Q98386353 | Mechanistic studies of cytotoxic activity of the mesoionic compound MIH 2.4Bl in MCF-7 breast cancer cells |
| Q37620713 | Metformin promotes autophagy and apoptosis in esophageal squamous cell carcinoma by downregulating Stat3 signaling |
| Q92445781 | Molecular Determinants of Cancer Therapy Resistance to HDAC Inhibitor-Induced Autophagy |
| Q36989867 | Mullerian inhibiting substance suppresses proliferation and induces apoptosis and autophagy in endometriosis cells in vitro. |
| Q90460482 | Nanoparticle Delivery of RIG-I Agonist Enables Effective and Safe Adjuvant Therapy in Pancreatic Cancer |
| Q35886625 | Neuronal cell death in neurodegenerative diseases: recurring themes around protein handling |
| Q60949491 | New Insights into the Role of Endoplasmic Reticulum Stress in Breast Cancer Metastasis |
| Q37585057 | New function of type I IFN: induction of autophagy |
| Q40434898 | Noncanonical Fungal Autophagy Inhibits Inflammation in Response to IFN-γ via DAPK1. |
| Q37132233 | Potent antitumor activity of oncolytic adenovirus expressing Beclin-1 via induction of autophagic cell death in leukemia |
| Q53038645 | Progesterone increases apoptosis and inversely decreases autophagy in human hepatoma HA22T/VGH cells treated with epirubicin. |
| Q38265625 | Regulation of autophagy by polyphenolic compounds as a potential therapeutic strategy for cancer |
| Q36670905 | Removal of the BH4 domain from Bcl-2 protein triggers an autophagic process that impairs tumor growth |
| Q92916951 | Role of Autophagy in Breast Cancer Development and Progression: Opposite Sides of the Same Coin |
| Q37368042 | Role of apoptosis in cardiovascular disease |
| Q38120523 | Role of the Crosstalk between Autophagy and Apoptosis in Cancer |
| Q37696302 | Sequential delivery of therapeutic agents using a rationally designed disulfide-linked glycolipid-like nanocarrier |
| Q24632721 | Silencing of p130cas in ovarian carcinoma: a novel mechanism for tumor cell death |
| Q34989052 | Silencing of the IKKε gene by siRNA inhibits invasiveness and growth of breast cancer cells |
| Q37152867 | Spindle and kinetochore associated complex subunit 1 regulates the proliferation of oral adenosquamous carcinoma CAL-27 cells in vitro |
| Q36009215 | Steroid receptor coactivator 3 regulates autophagy in breast cancer cells through macrophage migration inhibitory factor |
| Q33635355 | Stimuli-Responsive Mesoporous Silica NPs as Non-viral Dual siRNA/Chemotherapy Carriers for Triple Negative Breast Cancer |
| Q38959517 | Tackling breast cancer chemoresistance with nano-formulated siRNA. |
| Q36416427 | Targeted polymeric nanoparticles for cancer gene therapy |
| Q34387697 | Targeted silencing of elongation factor 2 kinase suppresses growth and sensitizes tumors to doxorubicin in an orthotopic model of breast cancer |
| Q49545616 | Targeting Autophagy in ALK-Associated Cancers. |
| Q39706185 | Targeting Bcl-2-mediated cell death as a novel therapy in pancreatic cancer |
| Q64977661 | Targeting Protein Quality Control Mechanisms by Natural Products to Promote Healthy Ageing. |
| Q34023616 | Targeting autophagy in breast cancer. |
| Q26782468 | Targeting autophagy in cancer management - strategies and developments |
| Q39066768 | Targeting elongation factor-2 kinase (eEF-2K) induces apoptosis in human pancreatic cancer cells |
| Q38671036 | Targeting mitotic pathways for endocrine-related cancer therapeutics |
| Q37707832 | Targeting the prodeath and prosurvival functions of autophagy as novel therapeutic strategies in cancer |
| Q38874839 | The PARP inhibitor AZD2281 (Olaparib) induces autophagy/mitophagy in BRCA1 and BRCA2 mutant breast cancer cells. |
| Q38861044 | The Phytoestrogen Genistein Affects Breast Cancer Cells Treatment Depending on the ERα/ERβ Ratio. |
| Q37902052 | The autophagic paradox in cancer therapy |
| Q34275855 | The importance of autophagy regulation in breast cancer development and treatment. |
| Q57291210 | The multifaceted role of autophagy in cancer and the microenvironment |
| Q37378496 | The paradox of autophagy and its implication in cancer etiology and therapy |
| Q37553966 | The role of X-box binding protein-1 in tumorigenicity. |
| Q33637380 | Therapeutic Silencing of Bcl-2 by Systemically Administered siRNA Nanotherapeutics Inhibits Tumor Growth by Autophagy and Apoptosis and Enhances the Efficacy of Chemotherapy in Orthotopic Xenograft Models of ER (-) and ER (+) Breast Cancer |
| Q36243019 | Time depended Bcl-2 inhibition might be useful for a targeted drug therapy. |
| Q28395046 | Toxicological considerations when creating nanoparticle-based drugs and drug delivery systems |
| Q36685448 | Tumor growth suppression by inhibiting both autophagy and STAT3 signaling in HNSCC. |
| Q38840273 | miR-15a enhances the anticancer effects of cisplatin in the resistant non-small cell lung cancer cells |
| Q55413938 | miR-519a enhances chemosensitivity and promotes autophagy in glioblastoma by targeting STAT3/Bcl2 signaling pathway. |
Search more.